416 related articles for article (PubMed ID: 29020904)
21. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.
Chamberlain AJ; Fritschi L; Giles GG; Dowling JP; Kelly JW
Arch Dermatol; 2002 May; 138(5):609-14. PubMed ID: 12020221
[TBL] [Abstract][Full Text] [Related]
22. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
23. Association of clinicopathological features of melanoma with total naevus count and a history of dysplastic naevi: a cross-sectional retrospective study within an academic centre.
Tan SY; Strazzulla LC; Li X; Park JJ; Lee SJ; Kim CC
Clin Exp Dermatol; 2018 Jul; 43(5):566-572. PubMed ID: 29450912
[TBL] [Abstract][Full Text] [Related]
24. Impact of naevus association on survival for nodular and superficial spreading melanomas.
Vu M; Adler NR; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
Br J Dermatol; 2018 Sep; 179(3):761-762. PubMed ID: 29573395
[No Abstract] [Full Text] [Related]
25. Dysplastic nevus syndrome with multiple primary amelanotic melanomas in oculocutaneous albinism.
Pehamberger H; Hönigsmann H; Wolff K
J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):731-5. PubMed ID: 6490997
[TBL] [Abstract][Full Text] [Related]
26. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
27. A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences.
Dessinioti C; Geller AC; Stergiopoulou A; Dimou N; Lo S; Keim U; Gershenwald JE; Haydu LE; Dummer R; Mangana J; Hauschild A; Egberts F; Vieira R; Brinca A; Zalaudek I; Deinlein T; Evangelou E; Thompson JF; Scolyer RA; Peris K; Garbe C; Stratigos AJ
Br J Dermatol; 2021 Jul; 185(1):101-109. PubMed ID: 33454993
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
29. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
Shaikh WR; Xiong M; Weinstock MA
Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
[TBL] [Abstract][Full Text] [Related]
30. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma.
Scolyer RA; Zhuang L; Palmer AA; Thompson JF; McCarthy SW
Pathology; 2004 Oct; 36(5):419-27. PubMed ID: 15370111
[TBL] [Abstract][Full Text] [Related]
31. Melanoma in association with acquired melanocytic nevus in Japan: a review of cases in the literature.
Togawa Y; Nakamura Y; Kamada N; Kambe N; Takahashi Y; Matsue H
Int J Dermatol; 2010 Dec; 49(12):1362-7. PubMed ID: 21155082
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
Carli P; Massi D; Santucci M; Biggeri A; Giannotti B
J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
[TBL] [Abstract][Full Text] [Related]
33. Naevus-associated melanomas: cause or chance?
Massi D; Carli P; Franchi A; Santucci M
Melanoma Res; 1999 Feb; 9(1):85-91. PubMed ID: 10338338
[TBL] [Abstract][Full Text] [Related]
34. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
Dessinioti C; Dimou N; Geller AC; Stergiopoulou A; Lo S; Keim U; Gershenwald JE; Haydu LE; Ribero S; Quaglino P; Puig S; Malvehy J; Kandolf-Sekulovic L; Radevic T; Kaufmann R; Meister L; Nagore E; Traves V; Champsas GG; Plaka M; Dreno B; Varey E; Ramirez DM; Dummer R; Mangana J; Hauschild A; Egberts F; Peris K; Del Regno L; Forsea AM; Zurac SA; Vieira R; Brinca A; Zalaudek I; Deinlein T; Linos E; Evangelou E; Thompson JF; Scolyer RA; Garbe C; Stratigos AJ
J Natl Cancer Inst; 2019 Dec; 111(12):1314-1322. PubMed ID: 30863861
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and associations of high-mitotic-rate melanoma.
Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW
JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970
[TBL] [Abstract][Full Text] [Related]
36. The nature of melanoma. A critical review.
McGovern VJ
J Cutan Pathol; 1982 Apr; 9(2):61-81. PubMed ID: 7047599
[TBL] [Abstract][Full Text] [Related]
37. Observational study on the mitotic rate and other prognostic factors in cutaneous primary melanoma arising from naevi and from melanoma de novo.
Betti R; Santambrogio R; Cerri A; Vergani R; Moneghini L; Menni S
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1738-41. PubMed ID: 24673663
[TBL] [Abstract][Full Text] [Related]
38. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
39. [Melanoma in invisible naevus spilus].
Livory M; Descamps V; Pelletier F; Maubec E; Faivre B; Marinho E; Humbert P; Crickx B; Aubin F
Ann Dermatol Venereol; 2008 Jan; 135(1):48-52. PubMed ID: 18342074
[TBL] [Abstract][Full Text] [Related]
40. [Epiluminescence microscopic characteristics of small malignant melanoma].
Schulz H
Hautarzt; 1997 Dec; 48(12):904-9. PubMed ID: 9486362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
